Vera Therapeutics, Inc.
VERA
$21.71
-$0.32-1.45%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -175.46M | -152.15M | -134.38M | -107.85M | -94.30M |
| Total Depreciation and Amortization | 1.66M | 1.59M | 1.53M | 1.52M | 538.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 16.70M | 13.22M | 10.89M | 9.05M | 9.53M |
| Change in Net Operating Assets | 1.84M | 2.66M | 1.31M | -9.45M | -15.48M |
| Cash from Operations | -155.26M | -134.68M | -120.64M | -106.73M | -99.72M |
| Capital Expenditure | -1.16M | -972.00K | -390.00K | -152.00K | -63.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -189.27M | -424.06M | -184.70M | -207.03M | -270.89M |
| Cash from Investing | -190.43M | -425.03M | -185.09M | -207.18M | -270.95M |
| Total Debt Issued | -- | -- | 24.74M | 24.74M | 24.74M |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 353.04M | 645.91M | 298.69M | 298.23M | 295.23M |
| Repurchase of Common Stock | -13.00K | -13.00K | -13.00K | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -21.36M | -39.23M | -17.87M | -17.87M | -17.87M |
| Cash from Financing | 331.67M | 606.67M | 305.55M | 305.10M | 302.10M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -14.02M | 46.97M | -185.00K | -8.80M | -68.57M |